YORK University is hosting an international conference on lymphomas, the most common type of cancers of the blood in the developed world.
The conference, B-cell malignancies: the impact of biomarkers on treatment decisions, will be held on the University's Heslington campus on Friday May 10.
Hosted by the Epidemiology and Cancer Statistics Group the one-day event is organised by the Haematological Malignancy Research Network..
It is also held in association with an international initiative dedicated to identifying and evaluating biomarkers (biological characteristics used to diagnose disease or predict treatment response) that will improve lymphoma detection and treatment.
The conference brings together distinguished research scientists from around the world and will be attended by academics, researchers, students, pharmaceutical industry workers and NHS practitioners, including consultants and clinical nurse specialists.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here